Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-05-28

FDA Approved: TAUVID — Original Application (Eli Lilly and Company)

View source ↗

Summary

FDA approved Tauvid (flortaucipir F-18) for PET imaging to estimate tau neurofibrillary tangles in the brains of adult patients with known or suspected neurodeg…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tauvid (Flortaucipir (18F))

Snippet

ORIG AP for TAUVID (FLORTAUCIPIR F-18)